Follow-The-Filings

Security

WST

West Pharmaceutical Svsc Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

20 owners 1 new max 1.6% (Hillman Capital Managemen...)

grid → activity →
owners 20
rank #214
master % 0.06%
max % 1.6%
tracked value $5.7B
qoq N 1 A 8 R 7

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Hillman Capital Management, Inc. 2026 Q1 1.6% — 8,906 $2.2B hist
Gates Foundation Trust 2026 Q1 0.4% — 444,500 $111M hist
Andreas Halvorsen - Viking Global Investors LP 2026 Q1 0.3% Add +0.08 pp 416,948 $105M hist
Ron Baron - Bamco Inc. /NY/ (Baron Capital) 2026 Q1 0.2% Reduce -0.05 pp 199,750 $50M hist
Renaissance Technologies LLC 2026 Q1 0.1% Add +0.04 pp 209,660 $53M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.1% Reduce -0.02 pp 159,350 $40M hist
Two Sigma Investments, LP 2025 Q4 stale 0.1% Exit -0.05 pp 139,939 $39M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 9,539,173 $2.6B hist
Norges Bank 2025 Q4 stale 0.0% Exit -0.03 pp 988,737 $272M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce -0.04 pp 266,944 $67M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.0% Add +0.02 pp 23,161 $6M hist
Natixis Advisors, LLC 2026 Q1 0.0% Add 0.00 pp 62,572 $16M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 323,587 $81M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 7,066 $2M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 18,638 $5M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% New 0.0% 14,001 $4M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce -0.01 pp 13,775 $3M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce -0.01 pp 1,573 $394 hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% Reduce 0.00 pp 1,121 $281 hist
Ancora Advisors LLC 2026 Q1 0.0% Add 0.00 pp 71 $18 hist

20 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.95B $2.89B $3.07B
Gross profit $1.13B $998.5M $1.1B
Gross margin * 38.3% 34.5% 35.9%
Net income $593.4M $492.7M $493.7M
Net margin * 20.1% 17.0% 16.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.94B $1.54B $1.98B
Total non-current assets * $1.89B $2.11B $2.29B
Total assets $3.83B $3.64B $4.27B
Total current liabilities $671.8M $550.4M $654.9M
Total non-current liabilities * $276.7M $410.7M $439.1M
Total equity $2.88B $2.68B $3.18B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $776.5M $653.4M $754.8M
Cash from investing -$368.7M -$378.7M -$285.9M
Cash from financing -$459.6M -$622.6M -$185.1M
Net change in cash -$40.4M -$369.3M $306.7M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders